If you are currently looking into stocks which may have clocked strong gains on Wednesday then it may be a good time to perhaps look into the International Stem Cell Corporation (OTCMKTS:ISCO) stock, which ended up with gains of as much as 28% for the day.
Trading Data
On Wednesday, ISCO stock moved up 28% to $0.4870 with more than 61K shares, compared to its average Wednesday of 2.15K shares. The stock moved within a range of $0.3800 – 0.5100 after opening trade at $0.38.
International Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End Results
The clinical state biotech firm, which is based out of California, is involved in the development of biomedical products as well as therapies derived from stem cells. Yesterday, the company came into focus after it announced its financial results for the fourth fiscal quarter and for the fiscal year, both of which ended on December 31, 2021.
It may be a good time to take a look at the highlights from the financial results. The company managed to bring in revenues of $7.18 million in 2021, which worked out to a marginal rise from the $7.13 million in the previous year.
On the other hand, the net losses for the financial year came in at $899,000 and that reflected a significant decline of as much as 67% from the net losses of $2.72 million that it suffered in 2020. It now remains to be seen if the stock can add to its gains today or not.
Key Quote
“We are pleased with the outcome of our phase 1 clinical trial as we were able to show not only safety and tolerability, but also preliminary efficacy for ISC-hpNSC®. As an example, on average the quality of life of the patients as measured by the Parkinson’s Disease Quality of Life Score-39 Summary Index, improved 43% for the second cohort at twelve months post-transplantation. This improved to a 45% better score in the same at 48 months” stated Andrey Semechkin, Ph.D., CEO and Co-Chairman of ISCO.
Technical Data
ISCO stock is trading above the 20-Day and 50-Day Moving averages of $0.41 and $0.45 respectively. above, the stock is trading below the 200-Day moving average of $0.50.
